Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 456
Immune Disorders Drugs 193
Cardiovascular Drugs 157
Drug Discovery 148
Infectious Diseases Drugs 132
Biopharmaceuticals 127
Endocrine and Metabolic Disorders Drugs 111
Clinical Trials 107
Central Nervous System Drugs 105
Musculoskeletal Disorders Drugs 96
Pharmaceuticals 95
Leukemia Drugs 80
Hematological Drugs 77
Liver and Kidney Disorders Drugs 75
Lymphoma Drugs 62
Diabetes Drugs 57
Dermatological Drugs 57
Skin Cancer Drugs 48
Brain Cancer Drugs 46
Respiratory Drugs 45
Mental Disorders Drugs 43
Lung Cancer Drugs 39
Gastrointestinal Drugs 38
Pharmaceutical Intermediates 34
Drug Delivery 34
Immunosuppressive Drugs 33
Pharmaceutical Manufacturing 31
Infusions and Injectables 30
Liver Cancer Drugs 29
Analgesics 27
Antibiotics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Kidney Cancer Drugs 21
Pancreatic Cancer Drugs 19
Prostate Cancer Drugs 18
Urological Disorders Drugs 18
Colon Cancer Drugs 17
HIV/AIDS Drugs 17
Schizophrenia Drugs 17
Cervical Cancer Drugs 16
Sexual and Reproductive Health Drugs 16
Ovarian Cancer Drugs 15
Thyroid Cancer Drugs 14
Breast Cancer Drugs 13
Cancer Vaccines 13
Psoriasis Drugs 12
Over the Counter (OTC) Drugs 11
Biosimilars and Biosuperiors 11
Generic Drugs 10
Anti-Obesity Drugs 9
Optical Disorders Drugs 8
Vaccines 8
Transdermal and Transmucosal Drug Delivery 7
Alzheimer's Disease Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Cough and Cold Drugs 5
Anxiety Drugs 4
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Asthma Drugs 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Allergy Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



278 reviews

2,403 Results (Page 64 of 121)
- Relevance
  Sort by

Cancer Biologics Market Report 2023-2033

 Report
June 2023
308 Pages
Global

From

€4716EUR$5,529USD£3,950GBP

Artificial Intelligence (AI) in Biopharmaceuticals Market Report 2023-2033

 Report
June 2023
218 Pages
Global

From

€4716EUR$5,529USD£3,950GBP

Splenomegaly Therapeutics - Global Strategic Business Report

 Report
August 2025
169 Pages
Global

From

€5165EUR$5,850USD£4,477GBP

Gastric Motility Disorder Drugs - Global Strategic Business Report

 Report
August 2025
371 Pages
Global

From

€5165EUR$5,850USD£4,477GBP

Pulmonary Drugs Market by Product Type (Biologics, Bronchodilators, Combination Therapies), Route Of Administration (Inhalation, Injection, Oral), Distribution Channel, Indication, End User - Global Forecast 2025-2030

 Report
August 2025
193 Pages
Global

From

€3130EUR$3,545USD£2,713GBP

€3478EUR$3,939USD£3,015GBP

NEED HELP FINDING THE RIGHT PRODUCT? Craig will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Anti-Obesity Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

 Report
April 2023
137 Pages
Global

From

€4194EUR$4,750USD£3,635GBP

Geriatric Medicines - Global Strategic Business Report

 Report
August 2025
304 Pages
Global

From

€5165EUR$5,850USD£4,477GBP

Active Pharmaceutical Ingredients Market (API) by Molecule Type (Large Molecule, Small Molecule), Source (Biotech, Natural, Synthetic), Route Of Administration, Product Category, Therapeutic Application, Application - Global Forecast 2025-2030

 Report
August 2025
189 Pages
Global

From

€3130EUR$3,545USD£2,713GBP

€3478EUR$3,939USD£3,015GBP

Market Forecasts for Immuno-Oncology Diagnostics Including Executive/Consultant Guides and Customized Forecasting/Analysis

 Report
May 2025
472 Pages
Global

From

€6176EUR$6,995USD£5,354GBP

Branded PAH Therapeutics Market (2023 Edition) - Analysis By Drug Class, Route of Administration, Distribution Channel, By Region, By Country: Market Insights and Forecast (2019-2029)

 Report
November 2023
250 Pages
Global

From

€2163EUR$2,450USD£1,875GBP

Oncology Precision Medicine Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Type of Cancer Targeted, Route of Administration, Type of Molecule, Drug Class, Key Geographical Regions, Leading Drug Developers and Sales Forecast

 Report
February 2024
468 Pages
Global

From

€4237EUR$4,799USD£3,673GBP

Antithrombotic/Anticoagulant Drugs: Technologies and Global Markets

 Report
October 2023
157 Pages
Global

From

€4106EUR$4,650USD£3,559GBP

Central Nervous System Collaboration and Licensing Deals 2020-2025

 Report
April 2025
400 Pages
Global

From

€3527EUR$3,995USD£3,058GBP

Regenerative Medicine Market Report 2023-2033

 Report
March 2023
232 Pages
Global

From

€4716EUR$5,529USD£3,950GBP

Novel T-Cell Immunotherapies Market: Focus on T-Cells, Tregs, Activated T-Cells, Virus-driven T-Cells & T-Cell Vaccines - Distribution by Type of T-Cell Therapy, Target Indications , Key Players and Key Geographies: Industry Trends and Global Forecasts, 2021-2030

 Report
June 2021
193 Pages
Global

From

€4237EUR$4,799USD£3,673GBP

Pharmaceutical Industry in the United States 2022

 Report
September 2022
150 Pages
United States

From

€751EUR$850USD£651GBP

Live Biotherapeutic Products and Microbiome Manufacturing Market by Type of Product Manufactured, Type of Formulation, Type of Primary Packaging Used, Scale of Operation, Company Size and Key Geographical Regions: Industry Trends and Global Forecasts, 2022 - 2035

 Report
February 2022
305 Pages
Global

From

€4237EUR$4,799USD£3,673GBP

Neuropathic Pain - Global Strategic Business Report

 Report
August 2025
386 Pages
Global

From

€5165EUR$5,850USD£4,477GBP

Targeted Protein Degradation - Global Strategic Business Report

 Report
August 2025
384 Pages
Global

From

€5165EUR$5,850USD£4,477GBP

Microbial API - Global Strategic Business Report

 Report
August 2025
466 Pages
Global

From

€5165EUR$5,850USD£4,477GBP

2,403 Results (Page 64 of 121)
- 1
- 62
- 63
- 64
- 65
- 66

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.